mk 0663 has been researched along with HIV Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aaberge, I; Dahm, A; Dyrhol-Riise, AM; Kvale, D; Prebensen, C; Sandset, PM; Taskén, K; Trøseid, M; Ueland, T; Waalen, K | 1 |
1 trial(s) available for mk 0663 and HIV Infections
| Article | Year |
|---|---|
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.
Topics: Adult; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Progression; Etoricoxib; Female; HIV Infections; Humans; Immunity, Cellular; Male; Middle Aged; Pneumococcal Vaccines; Pyridines; Sulfones; T-Lymphocytes; Tetanus Toxoid | 2017 |